CRSP
CRISPR Therapeutics AG · Healthcare · Market cap $5.2B
Insiders sold $4.9M net in the last 90 days ·4 sellers, 0 buyers· 3 of 7 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 20, 2026
Insider Buying
$50K
reported purchases (SEC code P)
Insider Selling
$17.9M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Oct 20, 2026
Kulkarni Samarth
CRISPR Therapeutics AG (CRSP) has 27 SEC Form 4 filings (59 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Oct 20, 2026.
Inside the rolling window, 6 insiders at CRISPR Therapeutics AG reported 1 open-market purchase totaling $50K and 24 open-market sales totaling $17.9M. The most active filer is Chief Executive Officer Kulkarni Samarth with 8 filings. Insiders have net sold $5.1M over the trailing 6 months. The most recent open-market filing is a sale of 47,837 shares by Chief Executive Officer Kulkarni Samarth, dated Oct 19, 2026, worth $2.4M.
- Industry:Biotechnology
- CEO:Samarth Kulkarni
- Employees:393
- HQ:Zug, ZG, CH
- IPO:2016-10-19
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 47,837 | $2.4M | Oct 20 | +8.5% | SEC ↗ | |
| Director | Sale | 14,514 | $720K | Oct 16 | +9.9% | SEC ↗ | |
| General Counsel and Secretary | Sale | 1,040 | $51K | Oct 15 | +5.0% | SEC ↗ | |
Kulkarni SamarthFirst in 7 months | Chief Executive Officer | Sale | 4,098 | $202K | Oct 15 | +5.0% | SEC ↗ |
| General Counsel and Secretary | Sale | 1,990 | $119K | Oct 8 | +7.3% | SEC ↗ | |
KASINGER JAMES R.First in 6 months | General Counsel and Secretary | Sale | 10,400 | $626K | Sep 24 | -2.9% | SEC ↗ |
Behbahani AliFirst in 7 months | Director | Sale | 13,679 | $781K | Sep 21 | -7.2% | SEC ↗ |
| Chief Medical Officer | Sale | 3,786 | $211K | Jun 1 | -0.1% | SEC ↗ | |
| General Counsel and Secretary | Sale | 3,182 | $149K | Mar 24 | +16.5% | SEC ↗ | |
| Chief Financial Officer | Sale | 3,708 | $173K | Mar 24 | +16.5% | SEC ↗ | |
| Chief Executive Officer | Sale | 10,020 | $469K | Mar 24 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 9,869 | $476K | Mar 17 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 10,349 | $499K | Mar 17 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 3,150 | $152K | Mar 17 | — | SEC ↗ | |
| General Counsel and Secretary | Sale | 3,450 | $166K | Mar 17 | — | SEC ↗ | |
| General Counsel and Secretary | Sale | 2,800 | $148K | Mar 12 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 9,798 | $517K | Mar 12 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 6,967 | $366K | Feb 20 | — | SEC ↗ | |
KASINGER JAMES R.First filing | General Counsel and Secretary | Sale | 2,112 | $111K | Feb 20 | — | SEC ↗ |
Patel NaimishFirst filing | Chief Medical Officer | Purchase | 1,508 | $50K | Jan 27 | — | SEC ↗ |
| Chief Financial Officer | Sale | 34,972 | $2.1M | Jan 26 | — | SEC ↗ | |
Kulkarni SamarthFirst filing | Chief Executive Officer | Sale | 30,000 | $1.6M | Jan 22 | — | SEC ↗ |
Kulkarni SamarthFirst filing | Chief Executive Officer | Sale | 60,000 | $3.6M | Jan 22 | — | SEC ↗ |
| Chief Financial Officer | Sale | 29,700 | $1.8M | Jan 8 | — | SEC ↗ | |
Prasad RajuFirst filing | Chief Financial Officer | Sale | 10,000 | $560K | Dec 23 | — | SEC ↗ |
Congress trading CRSP 6 all-time
- DRep. Thomas SuozziOther$50,001 - $100,0002021-09-20
- RRep. Marjorie Taylor GreenePurchase$1,001 - $15,0002021-01-21
- RSen. James Mountain InhofeOther$1,001 - $15,0002021-01-05
- RSen. James Mountain InhofeOther$50,001 - $100,0002020-12-22
- RSen. James Mountain InhofeOther$15,001 - $50,0002018-06-19
- RSen. James Mountain InhofePurchase$15,001 - $50,0002017-10-19
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does CRSP have?
CRISPR Therapeutics AG (CRSP) has 27 SEC Form 4 filings (59 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Oct 20, 2026.
When was the most recent SEC Form 4 filing for CRSP?
The most recent Form 4 filing for CRSP on Tracefour is dated Oct 20, 2026.
Who is the most active insider at CRSP?
The most active SEC Form 4 filer at CRSP in the rolling window is Chief Executive Officer Kulkarni Samarth, with 8 filings.
What is the net insider flow at CRSP over the last 6 months?
Over the trailing 180 days, insiders at CRSP have net sold $5.1M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CRSP in the current window?
Inside the rolling window, insiders at CRSP bought $50K and sold $17.9M based on SEC Form 4 filings.
Can I get alerts for CRSP insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at CRISPR Therapeutics AG (CRSP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
CRISPR Therapeutics AG is in the Healthcare sector.